Recent Finacing
Recent Raise
Metabolic Solutions Development Company develops drug candidates targeting metabolic disease, including type 2 diabetes, conducting a multinational Phase 2b trial of MSDC-0160 and preparing Phase 1b/2a studies for MSDC-0602.
Focus Areas
Recent Investors
Funding round
Investors